Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

Treon Steven P.; Meid Kirsten; Gustine Joshua; Yang Guang; Xu Lian; Liu Xia; Patterson Christopher J.; Hunter Zachary R.; Branagan Andrew R.; Laubach Jacob P.; Ghobrial Irene M.; Palomba M. Lia; Advani Ranjana; Castillo Jorge J.

首页> 外文期刊>Journal of Clinical Oncology >Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

【24h】

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

机译：症状伊布勒替尼单疗法的长期随访，以前治疗沃尔德莫莫癌血症患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

PURPOSE We report the long-term findings and final analysis of a pivotal multicenter trial of ibrutinib monotherapy in previously treated patients with Waldenstrom macroglobulinemia (WM).

机译：目的：我们报告了一项重要的多中心试验的长期结果和最终分析，该试验采用伊布替尼单药治疗之前接受过瓦尔登斯特伦巨球蛋白血症（WM）治疗的患者。

著录项

来源
《Journal of Clinical Oncology》 |2021年第6期|共15页
作者
Treon Steven P.; Meid Kirsten; Gustine Joshua; Yang Guang; Xu Lian; Liu Xia; Patterson Christopher J.; Hunter Zachary R.; Branagan Andrew R.; Laubach Jacob P.; Ghobrial Irene M.; Palomba M. Lia; Advani Ranjana; Castillo Jorge J.;
展开▼
作者单位

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Harvard Med Sch Dept Med Boston MA 02115 USA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Stanford Univ Med Ctr Stanford CA 94305 USA;

Dana Farber Canc Inst Bing Ctr Waldenstroms Macroglobulinemia M548 450 Brookline Ave Boston MA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term follow-up of quality of life in high-risk patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis [J] . Marjo JAG De Ronde-Tillmans, Peter PT de Jaegere, Tom AJ de Jager, 老年心脏病学杂志（英文版） . 2018,第004期
2. Long-term follow-up of childhood low-risk ALL patients treated with SCMC-ALL-2005 protocol [J] . 胡文婷中国医学文摘：内科学分册（英文版） . 2013,第004期
3. Ibrutinib Monotherapy in Symptomatic, Treatment-Naive Patients With Waldenstrom Macroglobulinemia [J] . Treon Steven P., Gustine Joshua, Meid Kirsten, Journal of Clinical Oncology . 2018,第27期

机译：伊布洛替尼的单一疗法在症状，治疗 - 天真患者核心癌症
4. Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab. [J] . Treon SP, Soumerai JD, Hunter ZR, Blood: The Journal of the American Society of Hematology . 2011,第2期

机译：抗CD52单克隆抗体alemtuzumab治疗有症状的淋巴浆细胞性淋巴瘤/ Waldenstrom巨球蛋白血症的患者的长期随访。
5. Extended follow-up with the Bruton's tyrosine kinase inhibitor ibrutinib in previously treated Waldenstrom's macroglobulinemia [J] . Furman Richard R., Luan Ying, Bilotti Elizabeth, Leukemia and lymphoma . 2017,第5a6期

机译：在以前治疗的沃尔德莫尔莫氏植物血症中延长了与Bruton的酪氨酸激酶抑制剂Ibrutinib的跟进
6. Comparison of Three Laboratory-Developed Tests for Detection of the MYD88 L265P Mutation in Differential Diagnosis of Waldenstrom Macroglobulinemia [C] . Kok Siong Poon, Te Chih Liu, Evelyn Siew Chuan Koay Molecular Medicine TRI-CON.;Conferences healthtech . 2014

机译：三种实验室开发的试验检测核核胰岛血症差异诊断中的三种实验室开发的试验
7. Long-term follow-up of patients treated with the edgewise crowned Herbst appliance in the mixed dentition. [D] . Wigal, Timothy G. 2008

机译：在混合牙列中使用经边缘加冠的Herbst矫治器治疗的患者的长期随访。
8. Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia [O] . Aristea-Maria Papanota, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, 2019

机译：评价依鲁替尼治疗有症状的沃尔登斯特罗姆巨球蛋白血症
9. CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib [O] . Vos, Josephine M., Tsakmaklis, Nickolas, Patterson, Christopher J., 2017

机译：Waldenstrom巨球蛋白血症患者的CXCL13水平升高，并预测对依鲁替尼有重大反应
10. Practical and theoretical implications based on long-term follow-up of Meniere's patients treated with streptomycin sulfate [R] . Fregly, A. R., Graybiel, A., Mc Leod, M. E., 1965

机译：基于美尼尔治疗硫酸链霉素的长期随访的实际和理论意义

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

摘要

著录项

相似文献

相关主题

期刊订阅